Endocrine Abstracts

Introduction: Metabolic disturbances that are common in polycystic ovary syndrome (PCOS), represent a risk factor for cardiovascular disease. The aim of this study was to define contribution of obesity for the development of dyslipidemia and insulin resistance in PCOS.Methods: PCOS was diagnosed using ESHRE/ASRM criteria. We evaluated 158 women with PCOS who were divided into two subgroups according to body mass index (BMI) cut off value 25 kg/m2</s...

Introduction: Women with polycystic ovary syndrome (PCOS) have higher prevalence of metabolic syndrome (MS) than healthy, age and BMI matched women. The aim of this study was to determine if novel abdominal adiposity index – lipid accumulation product (LAP), could predict MS in women with PCOS.Methods: PCOS was diagnosed using ESHRE/ASRM criteria. We evaluated 159 PCOS women (PCOS group: 24.9±6.2 kg/m2; 25.8±5.4 years) and 56 he...